Skip to main content
10/12/2024

VHIR participates in the EU Project SPM4.0

Fotografia de l'equip del projecte d'IBEC

10/12/2024

Researchers from all over Europe gathered to kick off the SPM4.0 project, an innovative Marie Curie Skłodowska (MSCA-DN) doctoral network that promotes the development of autonomous Scanning Probe Microscopy with AI.

Researchers from across Europe gathered for the kick-off meeting of the SPM4.0 project, an innovative Marie Curie Skłodowska Doctoral Network (MSCA-DN) dedicated to advancing the capabilities of autonomous Scanning Probe Microscopy (SPM) powered by Artificial Intelligence. The event, marked the beginning of a forward-thinking initiative aimed at training a new generation of researchers to push the boundaries of technology within the Life Sciences and Medical fields.

On the 13th and 14th of November, took place in Barcelona the kick-off meeting of the SPM4.0 EU project, a consortium of 12 beneficiaries and 10 associated partners from 8 different European countries. The project will be coordinated by Gabriel Gomila, Professor at the University of Barcelona and Principal Investigator of IBEC, and at VHIR will be led by Dr. Fernanda Andrade from the Clinical Biochemistry, Drug Delivery and Therapy (CB-DDT).

The SPM4.0 project aims to facilitate the widespread adoption of Scanning Probe Microscopy technologies in public and private research centers, industry and metrology institutions. Its goal is to explore new opportunities in the life sciences and medical sectors, focusing on label-free nanoscopic cell imaging, disease diagnosis and drug nanocarrier development, thereby strengthening Europe’s position as a world leader. The CB-DDT group will be involved in the development of nanoparticles for cancer stem cells targeting and enhanced cancer treatment. SPM4.0 technologies will be developed to allow label-free nanoparticles cellular tracking and correlate the internalization efficiency of nanoparticles targeting CSC with the nanoparticles’ and cells’ surface chemistry and physical (mechanical, electrical) nanoscale properties.

As part of the Marie Skłodowska-Curie Actions Doctoral Networks (MSCA-DN) programme, the SPM4.0 project will be funded for 4 years with almost 3.9 million euros. During this period, 16 young researchers will be trained in the science and technology of autonomous Scanning Probe Microscopes powered by Artificial Intelligence. In addition to their scientific education, this new generation of researchers will also receive training in complementary skills to prepare them for the research job market. They will participate in training sessions on data management, open science, scientific communication, intellectual property rights and entrepreneurship among others.

The kick-off meeting concluded with a strong endorsement of the project’s ambitious vision, inspiring all participants to embark on a journey that promises to reshape the future of microscopic imaging in critical research areas, promising transformative impacts in both science and technology.

 

For further updates, please check the SPM4.0 project website (available soon) and #SPM40 on social media channels.
Funded by the European Union under grant agreement ID: 101168976. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Logo European Union

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Related professionals

Mª Pilar Felipe Fernandez

Mª Pilar Felipe Fernandez

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Alba Estela García Fernández

Alba Estela García Fernández

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Fernando Moreno Flores

Fernando Moreno Flores

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
José Antonio Arranz  Amo

José Antonio Arranz Amo

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.